• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>ICO

ICO

  1. UPDATE: Why a surge in coffee-bean prices may not hit the Starbucks set--yet

    UPDATE: Why a surge in coffee-bean prices may not hit the Starbucks set--yet

  2. Global Candidiasis Pipeline Review, H2 2016 - Analysis, Technologies & Forecasts - Key Vendors: Amplyx Pharma, Bakker Medical, Biosergen - Research and Markets

    Global Candidiasis Pipeline Review, H2 2016 - Analysis, Technologies & Forecasts - Key Vendors: Amplyx Pharma, Bakker Medical, Biosergen - Research and Markets

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.